International Isotopes Inc. (INIS)
- Previous Close
0.0425 - Open
0.0380 - Bid --
- Ask --
- Day's Range
0.0380 - 0.0420 - 52 Week Range
0.0200 - 0.1000 - Volume
5,500 - Avg. Volume
61,880 - Market Cap (intraday)
21.843M - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date May 14, 2024 - May 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, rod sources, flexible and rigid rulers, spot and pen point markers, and various specialty design items. The Cobalt Products segment produces bulk cobalt; fabricates cobalt capsules for radiation therapy and various industrial applications; and recycles expended cobalt sources. The Radiochemical Products segment produces and distributes various isotopically pure radiochemicals and sodium iodide I-131 generic drug product for medical, industrial, and research applications. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
www.intisoid.com39
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: INIS
Performance Overview: INIS
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INIS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INIS
Valuation Measures
Market Cap
21.84M
Enterprise Value
23.44M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.77
Price/Book (mrq)
5.41
Enterprise Value/Revenue
1.91
Enterprise Value/EBITDA
-122.31
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.08%
Return on Assets (ttm)
-2.93%
Return on Equity (ttm)
-20.74%
Revenue (ttm)
12.27M
Net Income Avi to Common (ttm)
-869.02k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.69M
Total Debt/Equity (mrq)
206.72%
Levered Free Cash Flow (ttm)
561.32k
Company Insights: INIS
INIS does not have Company Insights